60
Odyssey Therapeutics, Inc. raises $214M under Reg D
Company raise · Closed · BOSTON, MA · Form D filed 2025-12-04
$50M+ raiseFirst raise on EDGAR
Why now — by persona
Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO. Lead card pending.
People on the filing
| Valerie D. Odegard | Director |
| Carl D. Gordon | Director |
| Carolyn F. Ng | Director |
| Gary D. Glick | Executive Officer, Director |
| Timothy D. Walbert | Director |
| Paulina D. Hill | Director |
| Nan D. Li | Director |
| Jeffrey D. Leiden | Director |
| Jason F. Haas | CFO |
| Nia F. Tatsis | Director |
| Ksenija F. Pavletic | Director |
| Shelley F. Chu | Director |
| lan F. Smith | Director |
| Jill D. Carroll | Director |
Signed by Gary D. Glick, President & CEO.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.